share_log

DA Davidson Downgrades Medifast to Neutral, Lowers Price Target to $106

Benzinga Real-time News ·  Nov 4, 2022 09:56

DA Davidson analyst Linda Bolton Weiser downgrades Medifast (NYSE:MED) from Buy to Neutral and lowers the price target from $278 to $106.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment